{"id":3753,"date":"2025-11-09T18:54:56","date_gmt":"2025-11-09T17:54:56","guid":{"rendered":"https:\/\/neurocirugialmeria.com\/?p=3753"},"modified":"2025-11-09T18:54:56","modified_gmt":"2025-11-09T17:54:56","slug":"pronostico-de-astrocitoma-grado-iv-idh-mutado","status":"publish","type":"post","link":"https:\/\/neurocirugialmeria.com\/en\/2025\/11\/09\/pronostico-de-astrocitoma-grado-iv-idh-mutado\/","title":{"rendered":"Pron\u00f3stico de Astrocitoma grado IV IDH mutado"},"content":{"rendered":"<p class=\"has-text-align-center\">La revista Neuro Oncology acaba de publicar un trabajo que analiza esta cuesti\u00f3n. Se trata de un estudio retrospectivo en el que fueron incluidos un total de 128 pacientes con diagn\u00f3stico de astrocitoma grado IV IDH mutado.<\/p>\n\n\n\n<p class=\"has-text-align-center\">Los autores observaron una edad media de 37 a\u00f1os al diagn\u00f3stico siendo el 60% de los afectados varones. La mediana de supervivencia se situ\u00f3 en 5,9 a\u00f1os con un intervalo libre de progresi\u00f3n de 2,7 a\u00f1os tras la primera l\u00ednea de tratamiento.<\/p>\n\n\n\n<p class=\"has-text-align-center\">Los pacientes mayores de 50 a\u00f1os con una delecci\u00f3n homocigota del gen CDKN2A\/2B asociaron un pron\u00f3stico significativamente peor. El grado de resecci\u00f3n obtenido de la regi\u00f3n captante de contraste en la RM postoperatoria estuvo asociado a una mayor supervivencia. Sin embargo, el estado del gen MGMT no asocio diferencias en la supervivencia de estos pacientes.<\/p>\n\n\n\n<p><strong>Fuente:<\/strong> <a href=\"https:\/\/academic.oup.com\/neuro-oncology\/article-abstract\/27\/9\/2382\/8152959?redirectedFrom=fulltext&amp;login=false\">Lasica AB, Lan Z, Miller JJ, Jiao A, Pan I, Aker L, Prabhakar P, Japo J, Russ A, Westergaard C, Aquilanti E, Chukwueke U, Gonzalez Castro LN, McFaline Figueroa JR, Lee EQ, Nayak L, Beroukhim R, Batchelor TT, Cahill DP, Nakhate V, Lanman T, Pablo Ospina J, Stec N, Patel RV, Meredith DM, Bi WL, Reardon DA, Ligon KL, Huang RY, Wen PY, Youssef G. Clinical, molecular, and radiological predictors of prognosis in newly diagnosed astrocytoma, IDH-mutant, WHO grade 4. Neuro Oncol. 2025 Oct 14;27(9):2382-2398.\u00a0<\/a><\/p>\n\n\n\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>La revista Neuro Oncology acaba de publicar un trabajo que analiza esta cuesti\u00f3n. Se trata de un estudio retrospectivo en el que fueron incluidos un total de 128 pacientes con diagn\u00f3stico de astrocitoma grado IV IDH mutado. Los autores observaron una edad media de 37 a\u00f1os al diagn\u00f3stico siendo el 60% de los afectados varones&#8230;.<\/p>","protected":false},"author":183523340,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","advanced_seo_description":"","jetpack_seo_html_title":"","jetpack_seo_noindex":false,"_kadence_starter_templates_imported_post":false,"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"_wpas_customize_per_network":false,"jetpack_post_was_ever_published":false},"categories":[1771],"tags":[],"class_list":["post-3753","post","type-post","status-publish","format-standard","hentry","category-sin-categoria"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/pbS7CP-Yx","jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/neurocirugialmeria.com\/en\/wp-json\/wp\/v2\/posts\/3753","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neurocirugialmeria.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neurocirugialmeria.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neurocirugialmeria.com\/en\/wp-json\/wp\/v2\/users\/183523340"}],"replies":[{"embeddable":true,"href":"https:\/\/neurocirugialmeria.com\/en\/wp-json\/wp\/v2\/comments?post=3753"}],"version-history":[{"count":2,"href":"https:\/\/neurocirugialmeria.com\/en\/wp-json\/wp\/v2\/posts\/3753\/revisions"}],"predecessor-version":[{"id":3755,"href":"https:\/\/neurocirugialmeria.com\/en\/wp-json\/wp\/v2\/posts\/3753\/revisions\/3755"}],"wp:attachment":[{"href":"https:\/\/neurocirugialmeria.com\/en\/wp-json\/wp\/v2\/media?parent=3753"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neurocirugialmeria.com\/en\/wp-json\/wp\/v2\/categories?post=3753"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neurocirugialmeria.com\/en\/wp-json\/wp\/v2\/tags?post=3753"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}